cell and gene therapy world


Who will you sit next to and empower at Phacilitate Leaders Forum 2018?

by Michael Adeniya, Event Director, Phacilitate

we get better by empowering phacilitate blog

Conferences are a funny thing. 

Sometimes it's not the keynote presenter that creates the game-changing takeaway. As a conference organiser, you might find it ludicrous to hear me say that. After all, these are the people we shout about the most when we encourage you to buy a ticket! 

The thing that has the most impact on you can often be simple, like the person you sit next to for lunch who will inspire you to change the way you’re looking at a problem RIGHT NOW. Or the woman behind you in the queue at the bar that is now your new investor, supplier or customer. 

In Miami last year, Claudia Zylberberg, CEO of Akron Biotech said 11 words that my partner scribbled down; this quote still sits proudly on our we get better by empowering phacilitate blogfridge at home. ‘We get better by empowering the person that sits beside you’.

Who will you sit beside next week at Phacilitate Leaders Forum? Will you use it as an opportunity to empower them?

With so many conferences to pick from every year, it's getting harder to decide which will be the best to spend your money on. Which will give you the best opportunity to advance your pipeline or close your next deal? What if you looked at it a different way and asked yourself, 'Which forum can I use to inspire my community?'.

It's easy to look at the conference agenda and wonder what value can you extract from it. It's harder to ask, 'what can I put into this? Who can I empower? Can I inspire someone to one thing differently?' 

We're excited to see a record attendance at the Phacilitate Leaders Forum (combined with the World Stem Cell Summit) of over 1300 attendees and we're seeing several new organisations on the registration list, which is so encouraging!

we get better by empowering phacilitate blog

Rather than shout about all the unmissable keynotes, I thought I'd share a few sessions this year, that you could get involved in 'and empower' someone else...

Japan Symposium and Partnering Lunch

Have you bravely launched products in Asia? Do you have the lion's share of understanding of Japan's regulatory pathways? Join Takeda, Longeveron, FIRM and many other for an outdoors lunch on the upper terrace. 

Immuno-Oncology Collaborations Lunch

With so many combinations in I-O, it's so hard to find the right one for your product. Developers can't solve this alone and they need you! 

Immuno-Oncology HUB

Sometimes learning from people that have failed fast is great way to fast-track your path to success. The I-O Hub would be a great way to share your views on precision medicine approaches, biomarker solutions for patient response, using genomics in your clinical trials or next generation bioprocessing technologies.


With almost 50% more attendees than last year, hopefully some of the sessions above will help you find your tribe at the only whole eco-system event for advanced therapies. 



  • "The event reflected the fantastic growing enthusiasm around cell and gene therapy, including small and large companies, investors and regulators. It was great to see everyone so engaged and so positive. The event really gives you the “pulse” of what is happening right now in cell and gene therapy."
    Anne-Virginie Eggimann,
  • “Great program, great people, great venue.”
    Klaus Kühlcke
    Managing Director, EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.”
    Nathalie Clement
    Associate Director, Powell Gene Therapy Center, University of Florida
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • "It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives."
    Kurt Gielen
    Acquisition & Business Development Manager, BioMedical Materials, Chemelot Campus B.V.
  • “Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.”
    Steven Goodman
    Director, Strategy and Engagement, GSK